Postpartum Hemorrhage: Evidence-Based Prophylaxis

Postpartum hemorrhage (PPH) remains one of the leading causes of maternal morbidity and mortality worldwide, particularly in low-and middle-income countries.This article critically reviews pharmacological, mechanical and organizational prophylactic interventions aimed at reducing the incidence and severity of PPH.The administration of uterotonics, particularly oxytocin and misoprostol, combined with active management of the third stage of labor and the use of intrauterine tamponade devices, has shown effectiveness in immediate hemostasis and reduction of long-term complications.Standardized institutional protocols and obstetric emergency training are essential to optimize early recognition and rapid treatment of PPH, significantly improving clinical outcomes and maternal safety.